SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from ORAGENICS INC (OGEN) (CIK 0001174940) (OGEN) — Jul 11, 2018

ORAGENICS INC (OGEN) (CIK 0001174940)
Date: July 11, 2018 · CIK: 0001174940 · Accession: 0001193125-18-215939

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-224950

Date
July 11, 2018
Author
Nicholas Stergis
Form
CORRESP
Company
ORAGENICS INC (OGEN) (CIK 0001174940)

Letter

Ladenburg Thalmann & Co. Inc.

999 Vanderbilt Beach Road, Suite 200

Naples, Florida 34108

July 11, 2018

VIA FACSIMILE AND EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Washington, DC 20549

Re: ORAGENICS, INC.

Registration Statement on Form S-1 (Registration No. 333-224950)

Concurrence in Acceleration Request

Ladies and Gentlemen:

Ladenburg Thalmann & Co. Inc. (“Ladenburg”), as representative of the underwriters for the above-referenced offering, hereby concurs in the request by Oragenics, Inc. that the effective date of the above-referenced registration statement be accelerated to 4:30 p.m. (Eastern Time), or as soon as practicable thereafter, on July 12, 2018, pursuant to Rule 461 under the Securities Act. Ladenburg affirms that it is aware of its obligations under the Securities Act in connection with this offering.

Very truly yours,
LADENBURG THALMANN & CO. INC.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 Ladenburg Thalmann & Co. Inc.

999 Vanderbilt Beach Road, Suite 200

Naples, Florida 34108

 July 11, 2018

VIA FACSIMILE AND EDGAR

 U.S. Securities and
Exchange Commission

 Division of Corporation Finance

Washington, DC 20549

Re:
ORAGENICS, INC.

 Registration Statement on Form
S-1 (Registration No. 333-224950)

 Concurrence
in Acceleration Request

 Ladies and Gentlemen:

Ladenburg Thalmann & Co. Inc. (“Ladenburg”), as representative of the underwriters for the above-referenced
offering, hereby concurs in the request by Oragenics, Inc. that the effective date of the above-referenced registration statement be accelerated to 4:30 p.m. (Eastern Time), or as soon as practicable thereafter, on July 12, 2018, pursuant to
Rule 461 under the Securities Act. Ladenburg affirms that it is aware of its obligations under the Securities Act in connection with this offering.

 Very truly yours,

LADENBURG THALMANN & CO. INC.

By:

/s/ Nicholas Stergis

 Name:  Nicholas Stergis

Title:    Managing Director